Postoperative Medical Therapy After Surgical Treatment of Endometriosis: From Adjuvant Therapy to Tertiary Prevention

Journal of Minimally Invasive Gynecology

Volumn 21, Issue 3, 2014, Pages 328-334

  Somigliana, Edgardo ^a   Vercellini, Paolo ^a,b   Vigano, Paola ^c   Benaglia, Laura ^a   Busnelli, Andrea ^a,b   Fedele, Luigi ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Endometriosis; Estroprogestin; Recurrence

Indexed keywords

DANAZOL; GESTAGEN; GONADORELIN ANTAGONIST; ORAL CONTRACEPTIVE AGENT; DRUG COMBINATION; ESTROPROGESTIN; ETHINYLESTRADIOL; PREGNANE DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CONCEPTION; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GYNECOLOGIC SURGERY; HORMONAL THERAPY; HUMAN; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MENSTRUATION; META ANALYSIS (TOPIC); PATHOGENESIS; PELVIC PAIN; PERITONEUM ADHESION; POSTOPERATIVE CARE; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REHABILITATION CARE; REVIEW; DRUG COMBINATION; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE PERIOD; REHABILITATION; TISSUE ADHESION;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; ETHINYL ESTRADIOL; FEMALE; HUMANS; NORPREGNENES; PELVIC PAIN; POSTOPERATIVE PERIOD; RECURRENCE; TERTIARY PREVENTION; TISSUE ADHESIONS;

EID: 84897618089     PISSN: 15534650     EISSN: 15534669     Source Type: Journal    
DOI: 10.1016/j.jmig.2013.10.007     Document Type: Review

References (59)

1. Ozkan S., Murk W., Arici A. Endometriosis and infertility: epidemiology and evidence based treatments. Ann NY Acad Sci 2008, 1127:92-100.
2. Farquhar C. Endometriosis. BMJ 2007, 334:249-253.
3. Kitawaki J., Kado N., Ishihara H., Koshiba H., Kitaoka Y., Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 2002, 83:149-155.
4. Vercellini P., Crosignani P., Somigliana E. Viganò. "Waiting for Godot": a commonsense approach to the medical treatment of endometriosis. Hum Reprod 2011, 26:3-13.
5. Jacobson T.Z., Duffy J.M., Barlow D., Koninckx P.R., Garry R. Laparoscopic surgery for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2009, 4:CD001300.
6. Jacobson T.Z., Duffy J.M., Barlow D., Farquhar C., Koninckx P.R., Olive D. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev 2010, 1:CD001398.
7. Guo S.W. Recurrence of endometriosis and its control. Hum Reprod Update 2009, 15:441-461.
8. Vercellini P., Somigliana E., Viganò P., De Matteis S., Barbara G., Fedele L. The effect of second-line surgery on reproductive performance of women with recurrent endometriosis: a systematic review. Acta Obstet Gynecol Scand 2009, 88:1074-1082.
9. Vercellini P., Barbara G., Abbiati A., Somigliana E., Viganò P., Fedele L. Repetitive surgery for recurrent symptomatic endometriosis: what to do?. Eur J Obstet Gynecol Reprod Biol 2009, 146:15-21.
10. Burney R.O., Giudice L.C. Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012, 98:511-519.
11. Lousse J.C., Van Langendonckt A., Defrere S., Ramos R.G., Colette S., Donnez J. Peritoneal endometriosis is an inflammatory disease. Front Biosci (Elite Ed) 2012, 4:23-40.
12. Viganò P., Somigliana E., Gentilini D., Benaglia L., Vercellini P. Back to the original question in endometriosis: implantation or metaplasia?. J Endometriosis 2009, 1:1-8.
13. Halme J., Hammond M.G., Hulka J.F., Raj S.G., Talbert L.M. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984, 64:151-154.
14. Evers J.L., Dunselman G.A., Land J.A., et al. Management of recurrent endometriosis (chapter 39). Progress in the Management of Endometriosis 1995, 291-297. Parthenon Publishing Group Ltd, London. E.M. Coutinho, P. Spinola, L. de Moura (Eds.).
15. Thomas S.L., Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women?. Lancet 2000, 11:922-924.
16. Vercellini P., Crosignani P., Somigliana E., et al. The "incessant menstruation" hypothesis: a mechanistic ovarian cancer model with implications for prevention. Hum Reprod 2011, 26:2262-2273.
17. Somigliana E., Vigano P., Benaglia L., Crovetto F., Vercellini P., Fedele L. Endometriosis in a rural remote setting: a cross-sectional study. Gynecol Endocrinol 2012, 28:979-982.
18. Vercellini P., Somigliana E., Viganò P., De Matteis S., Barbara G., Fedele L. Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online 2010, 21:259-265.
19. Viganò P., Vanni V.S., Corti L., et al. Unravelling the ovarian endometrioma pathogenesis: "The long and winding road" across the various theories. J Endometriosis 2013, 5:62-67.
20. Jain S., Dalton M.E. Chocolate cysts from ovarian follicles. Fertil Steril 1999, 72:852-856.
21. Vercellini P., Somigliana E., Vigano P., Abbiati A., Barbara G., Fedele L. "Blood on the Tracks" from corpora lutea to endometriomas. BJOG 2009, 116:366-371.
22. Vercellini P., De Matteis S., Somigliana E., Buggio L., Frattaruola M.P., Fedele L. Long-term adjuvant therapy for the prevention of postoperative endometriomas recurrence: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2013, 92:8-16.
23. Garcia A.A., Thigpen J.T. Principles of chemotherapy. Synopsis of Gynecologic Oncology 1998, 391-437. Churchill Livingston, New York. 5th ed. C.P. Morrow, J.P. Curtin (Eds.).
24. Redwine D.B. "Invisible" microscopic endometriosis: a review. Gynecol Obstet Invest 2003, 55:63-67.
25. Furness S., Yap C., Farquhar C., Cheong Y.C. Pre and post-operative medical therapy for endometriosis surgery. Cochrane Database Syst Rev 2004, 3:CD003678.
26. Paulson R.J., Boostanfar R., Saadat P., et al. Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age. JAMA 2002, 288:2320-2323.
27. Vercellini P., Crosignani P.G., Fadini R., Radici E., Belloni C., Sismondi P. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol 1999, 106:672-677.
28. Seracchioli R., Mabrouk M., Manuzzi L., et al. Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis. Hum Reprod 2009, 24:2729-2735.
29. Koga K., Osuga Y., Takemura Y., Takamura M., Taketani Y. Recurrence of endometrioma after laparoscopic excision and its prevention by medical management. Front Biosci (Elite Ed) 2013, 5:676-683.
30. Wu L., Wu Q., Liu L. Oral contraceptive pills for endometriosis after conservative surgery: a systematic review and meta-analysis. Gynecol Endocrinol 2013, 29:883-890.
31. Hee L., Kettner L.O., Vejtorp M. Continuous use of oral contraceptives: an overview of effects and side-effects. Acta Obstet Gynecol Scand 2013, 92:125-136.
32. Streuli I., de Ziegler D., Santulli P., et al. An update on the pharmacological management of endometriosis. Expert Opin Pharmacother 2013, 14:291-305.
33. Vercellini P., Frontino G., De Giorgi O., Aimi G., Zaina B., Crosignani P.G. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril 2003, 80:305-309.
34. Seracchioli R., Mabrouk M., Frascà C., Manuzzi L., Savelli L., Venturoli S. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril 2010, 94:464-471.
35. Tanmahasamut P., Rattanachaiyanont M., Angsuwathana S., Techatraisak K., Indhavivadhana S., Leerasiri P. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. Obstet Gynecol 2012, 119:519-526.
36. Vercellini P., Somigliana E., Daguati R., Vigano P., Meroni F., Crosignani P.G. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol 2008, 198:504.e1-504.e5.
37. Takamura M., Koga K., Osuga Y., et al. Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Hum Reprod 2009, 24:3042-3048.
38. Seracchioli R., Mabrouk M., Frascà C., et al. Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial. Fertil Steril 2010, 93:52-56.
39. Lee D.Y., Bae D.S., Yoon B.K., Choi D. Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence. Hum Reprod 2010, 25:3050-3054.
40. Cucinella G., Granese R., Calagna G., et al. Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?. Arch Gynecol Obstet 2013, 288:821-827.
41. Abou-Setta A.M., Houston B., Al-Inany H.G., Farquhar C. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev 2013, 1:CD005072.
42. Somigliana E., Benaglia L., Viganò P., Candiani M., Vercellini P., Fedele L. Surgical measures for endometriosis-related infertility: a plea for research. Placenta 2011, 32(Suppl 3):S238-S242.
43. Raffi F., Metwally M., Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab 2012, 97:3146-3154.
44. Somigliana E., Berlanda N., Benaglia L., Viganò P., Vercellini P., Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril 2012, 98:1531-1538.
45. Vercellini P., Eskenazi B., Consonni D., et al. Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis. Hum Reprod Update 2011, 17:159-170.
46. Somigliana E., Vercellini P., Vigano P., Abbiati A., Benaglia L., Fedele L. Endometriosis and estroprogestins: the chicken or the egg causality dilemma. Fertil Steril 2011, 95:431-433.
47. Chapron C., Souza C., Borghese B., et al. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 2011, 26:2028-2035.
48. Guzick D.S., Huang L.S., Broadman B.A., Nealon M., Hornstein M.D. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain. Fertil Steril 2011, 95:1568-1573.
49. Kaser D.J., Missmer S.A., Berry K.F., Laufer M.R. Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms. J Pediatr Adolesc Gynecol 2012, 25:105-108.
50. Morelli M., Sacchinelli A., Venturella R., Mocciaro R., Zullo F. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients. J Obstet Gynaecol Res 2013, 39:985-990.
51. Vlahos N., Vlachos A., Triantafyllidou O., Vitoratos N., Creatsas G. Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study. Fertil Steril 2013, 100:1337-1342.
52. Brown J., Kives S., Akhtar M. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev 2012, 3:CD002122.
53. Vercellini P., Somigliana E., Consonni D., Frattaruola M.P., De Giorgi O., Fedele L. Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia. I: Effect on pain during intercourse and patient satisfaction. Hum Reprod 2012, 27:3450-3459.
54. Wong A.Y., Tang L.C., Chin R.K. Levonorgestrel-releasing intrauterine system (Mirena) and depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial. Aust N Z J Obstet Gynaecol 2010, 50:273-279.
55. Adamson G.D. Endometriosis Fertility Index: is it better than the present staging systems?. Curr Opin Obstet Gynecol 2013, 25:186-192.
56. D'Hooghe T.M., Denys B., Spiessens C., Meuleman C., Debrock C. Is the endometriosis recurrence rate increased after ovarian hyperstimulation?. Fertil Steril 2006, 86:283-290.
57. Benaglia L., Somigliana E., Vercellini P., et al. The impact of IVF procedures on endometriosis recurrence. Eur J Obstet Gynecol Reprod Biol 2010, 148:49-52.
58. Benaglia L., Somigliana E., Santi G., Scarduelli C., Ragni G., Fedele L. IVF and endometriosis-related symptom progression: insights from a prospective study. Hum Reprod 2011, 26:2368-2372.
59. Somigliana E., Vercellini P., Daguati R., Giambattista E., Benaglia L., Fedele L. Effect of delaying post-operative conception after conservative surgery for endometriosis. Reprod Biomed Online 2010, 20:410-415.